Sol-Millennium Medical Technology (Shanghai) Co., Ltd.

Sol-Millennium is a multinational company specializing in the research, development, manufacturing, and marketing of disposable medical devices. Headquartered in Chicago, USA, it has branches in Atlanta (USA), Warsaw (Poland), São Paulo (Brazil), and Shanghai Xuhui District Grand Gateway (China), which are responsible for market expansion, sales, and customer service in Asia-Pacific, North America, South America, and Europe respectively. Sol-Millennium currently holds over 100 patents related to its products worldwide, providing high-quality products and services to nurses and patients in nearly 50 countries.

Sol-Millennium is committed to providing our customers with high-quality, uniquely designed products, as well as localized clinical sales and convenient logistics services. At the same time, we are dedicated to working with our customers through continuous R&D improvements to offer more high-quality products that further meet their needs.
From 2012 to 2015, SOL-M won the Moroccan Ministry of Health's tender for the supply of safety syringes for four consecutive years;
From 2011 to 2015, SOL-M won the state of São Paulo, Brazil, tender for the supply of safety syringes for five consecutive years;
From 2013 to 2015, SOL-M won the city of São Paulo, Brazil, tender for the supply of safety syringes for three consecutive years;
In 2015, SOL-M won the Kuwaiti tender for the supply of safety needles;
In 2015, SOL-M, together with B.Braun, won the Scottish NHS tender for the supply of safety needles and blunt needles.

Every product we manufacture and sell has passed certification by industry quality management systems, including ISO, CE, INMETRO, FDA510(K), TFDA, TGA, etc.

Sol-Millennium's business model:
Focus on R&D - to achieve differentiation of main products from market competitors.
Focus on product line strategy - to complete the product line by continuously launching new products, increase customer stickiness and loyalty, and achieve stable and sustained revenue growth.
Focus on internationalization strategy - to provide localized marketing and convenient logistics services, thereby optimizing the expansion of segmented channels, getting as close to customers as possible, reducing time and communication costs, and obtaining higher sales profits. At the same time, SOLM will actively plan future localized manufacturing, R&D, and procurement strategies.
Focus on independent brand building - and through cooperation with key customers, develop ODM business in a controlled manner. (Currently, sales are 60% self-owned brands and 40% customer or co-brands)
Focus on automated manufacturing - outsourcing manufacturing of other products to strengthen control over supply chain, product quality, and costs, and improve the company's quality level and gross profit margin.

Sol-Millennium's core competitiveness:
Sales channels - competitive overseas sales channels – 170 overseas distributors, covering more than 50 countries.
Quality system - familiarity with the quality system requirements of the medical device industry in the United States, Europe, and other overseas countries.
Product patents - abundant product patents: more than 100 core technology patents, enough to support the launch of new products in the next 5 years.
Cooperation relationships - maintaining good cooperation with industry enterprises.

*